Microbix Biosystems Inc
TSX:MBX

Watchlist Manager
Microbix Biosystems Inc Logo
Microbix Biosystems Inc
TSX:MBX
Watchlist
Price: 0.225 CAD 4.65% Market Closed
Market Cap: CA$31.3m

Operating Margin

-8.5%
Current
Declining
by 12.3%
vs 3-y average of 3.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-8.5%
=
Operating Income
CA$-1.6m
/
Revenue
CA$18.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-8.5%
=
Operating Income
CA$-1.6m
/
Revenue
CA$18.6m

Peer Comparison

Country Company Market Cap Operating
Margin
CA
Microbix Biosystems Inc
TSX:MBX
30m CAD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

In line with most companies in Canada
Percentile
45th
Based on 4 855 companies
45th percentile
-8.5%
Low
-4 710 029.9% — -65.8%
Typical Range
-65.8% — 11%
High
11% — 71 100%
Distribution Statistics
Canada
Min -4 710 029.9%
30th Percentile -65.8%
Median -2.4%
70th Percentile 11%
Max 71 100%

Microbix Biosystems Inc
Glance View

Market Cap
31.3m CAD
Industry
Biotechnology

Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The firm manufactures a range of biological materials for the diagnostics industry, notably antigens (Antigen business) used in immunoassays and its quality assessment and proficiency testing controls (QAPs business). The firm operates in two segments: the development, manufacturing, and sales of antigens as materials for the medical diagnostic industry or as quality assessment products (as finished products) and viral transport medium (VTM) and the development and commercialization of products or technologies such as Kinlytic and . The Kinlyti urokinase, which is a biologic thrombolytic drug used to treat blood clots. The firm's catalogue of catalogue covers a range of pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually transmitted and insect-borne diseases. Its QAPs are available in over 30 countries.

MBX Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-8.5%
=
Operating Income
CA$-1.6m
/
Revenue
CA$18.6m
What is Microbix Biosystems Inc's current Operating Margin?

The current Operating Margin for Microbix Biosystems Inc is -8.5%, which is below its 3-year median of 3.9%.

How has Operating Margin changed over time?

Over the last 3 years, Microbix Biosystems Inc’s Operating Margin has decreased from 13.7% to -8.5%. During this period, it reached a low of -16.6% on Sep 30, 2023 and a high of 18.7% on Mar 31, 2024.

Back to Top